The spectrum of JAK2-positive myeloproliferative neoplasms.


The discovery of the JAK2V617F mutation triggered an unexpected flowering of basic and clinical studies in the field of myeloproliferative neoplasms (MPNs), resulting after just a few years in an exceptional amount of new information. One important consequence of those new findings was the modification of the World Health Organization classification and… (More)
DOI: 10.1182/asheducation-2012.1.561


2 Figures and Tables

Cite this paper

@article{Kiladjian2012TheSO, title={The spectrum of JAK2-positive myeloproliferative neoplasms.}, author={Jean-Jacques Kiladjian}, journal={Hematology. American Society of Hematology. Education Program}, year={2012}, volume={2012}, pages={561-6} }